Stay updated on Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Sign up to get notified when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.

Latest updates to the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded the Locations section with Kansas sites (Fairway and Westwood) and updated the revision to v3.3.3; removed the HHS Vulnerability Disclosure link and the Kansas Locations entry.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the banner about government funding and related operating-status notes from the page. Other content, including the study details and links, remains unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedNo significant changes detected between the two screenshots; the study record details (title, purpose, eligibility, interventions, and endpoints) remain unchanged.SummaryDifference0.5%

- Check91 days agoChange DetectedUpdated page now includes a government funding status notice and a new version v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat + Sirolimus in Advanced Malignancy Clinical Trial page.